Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Class A Common Stock, par value $0.01
Shares outstanding
315,976,000
Total 13F shares
109,021,244
Share change
-7,186,740
Total reported value
$1,544,805,998
Put/Call ratio
18%
Price per share
$14.17
Number of holders
150
Value change
-$98,023,386
Number of buys
69
Number of sells
67

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q1 2019

As of 31 Mar 2019, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 109,021,244 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Fosun International Ltd, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, TCW GROUP INC, and STATE STREET CORP. This page lists 150 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.